"Anti-Cancer Peptides from the Ras-P21 Proteins"
M.R. Pincus, M. Fenelus, E.S. Yahzdi, V.Adler, W.B. Bowne and J. Michl
Current Pharmaceutical Design, In press, (2011)
"The Anti-cancer peptide, PNC-27, adopts an hdm-2 binding conformation in solution and binds to hdm-2, uniquely expressed in the membranes of cancer cells, resulting in transmembrane pore formation and cancer cell death"
E.S. Yahzdi, W.B. Bowne, V. Adler, K.A. Sookraj, V. Wu, V. Shteyler, H. Patel, W. Oxbury, P. Brandt-Rauf, M.E. Zenilman, J. Michl and M.R. Pincus
Proceedings of the National Academy of Science USA, 107 (5): 1918-23 (February 2010)
"PNC-27 acts as the intact peptide in inducing pore formation to occur in the membranes of cancer cells"
K.A. Sookraj, W.B. Bowne, V. Adler, E.S. Yhazdi, V. Wu, H. Patel, W. Oxbury, J. Michl and M.R. Pincus
Cancer, Chemotherapy, and Pharmacology, 66(2):325-31 (July 2010)
"Perforated Appendicitis Presenting as a Thigh Mass"
K.A. Sookraj, W.B. Bowne and B.C. Ghosh
The Journal of the American College of Surgeons, 208, (6): 1142 (2009)
"IgE Antibodies from Pancreatic Cancer Patients Mediate Antibody-Dependent Cell Mediated Cytotoxicity (ADCC) Against Pancreatic Cancer Cells"
S.L. Fu, S.L. Pierre, T. Smith-Norowitz, M. Hagler, W.B. Bowne, M.R. Pincus, C.M. Mueller, M.E. Zenilman and M.H. Bluth
Clinical and Experimental Immunology, 153(3):401-9 (September 2008)
"Sophorolipids and their Derivatives are Lethal Against Human Pancreatic Cancer Cells"
S. Fu, S. Wallner, W.B. Bowne, M.E. Zenilman, R. Gross and M.H. Bluth
Journal of Surgical Research, 148 (1): 77-82 (2008)
"Two Peptides Derived from ras-p21 Induces Either Phenotypic Reversion or Tumor Cell Necrosis of ras-Transformed Human Cancer Cells"
V. Adler, W.B. Bowne, K. Ikram, J. Michl, F.K. Friedman, E. Chin, M.E. Zenilman and M.R. Pincus
Cancer, Chemotherapy and Pharmacology, 62(3):491-8 (August 2008)
"The Role of the Assistant in Laparoscopic Surgery: Important Considerations for the Apprentice in Training"
A. Chui, W.B. Bowne, K.A. Sookraj, A. Fingerhut, M.E. Zenilman and G.S. Ferzli
Surgical Innovation, 15(3):229-36 (September 2008)